𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A novel series of [3.2.1] azabicyclic biaryl ethers as α3β4 and α6/4β4 nicotinic receptor agonists

✍ Scribed by John A. Lowe III; Shari L. DeNinno; Jotham W. Coe; Lei Zhang; Scot Mente; Raymond S. Hurst; Robert J. Mather; Karen M. Ward; Alka Shrikhande; Hans Rollema; David E. Johnson; Weldon Horner; Roxanne Gorczyca; F. David Tingley III; Rouba Kozak; Mark J. Majchrzak; Theresa Tritto; Jen Sadlier; Chris L. Shaffer; Brenda Ellerbrock; Sarah M. Osgood; Mary C. MacDougall; Laura L. McDowell


Publisher
Elsevier Science
Year
2010
Tongue
English
Weight
243 KB
Volume
20
Category
Article
ISSN
0960-894X

No coin nor oath required. For personal study only.

✦ Synopsis


We report the synthesis of a series of [3.2.1]azabicyclic biaryl ethers as selective agonists of a3and a6-containing nicotinic receptors. In particular, compound 17a from this series is a potent a3b4 and a6/4b4 receptor agonist in terms of both binding and functional activity. Compound 17a also shows potent in vivo activity in CNS-mediated animal models that are sensitive to antipsychotic drugs.

Compound 17a may thus be a useful tool for studying the role of a3b4 and a6/4b4 nicotinic receptors in CNS pharmacology.


📜 SIMILAR VOLUMES